India, July 23 -- PharmEasy-owned diagnostics laboratories chain Thyrocare's consolidated net profit rose 59.9% to INR 38.3 Cr in Q1 FY26 from INR 23.9 Cr in the year-ago quarter. Sequentially, profit rose 77.5% from INR 21.6 Cr.

Operating revenue grew 23% to INR 193.03 Cr during the quarter under review from INR 156.91 Cr in Q1 FY25. Sequentially, it rose 3.13% from INR 187.16 Cr.

Including other income of INR 4.65 Cr, the company's total income jumped 23% to INR 197.68 Cr from INR 160.53 Cr in the same quarter last year.

Meanwhile, expenses went up 16.4% to INR 147.45 Cr from INR 126.62 Cr in Q1 FY25.

(The story will be updated soon)

The post PharmEasy-Owned Thyrocare's Q1 Profit Rises 60% To INR 38.3 Cr appeared first on Inc42 Med...